US 10525051
Compositions and methods for achieving sustained therapeutic drug concentrations in a subject
granted A61KA61K31/4745A61K47/60
Quick answer
US patent 10525051 (Compositions and methods for achieving sustained therapeutic drug concentrations in a subject) held by Nektar Therapeutics expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/4745, A61K47/60, A61P, A61P15/00